QT Imaging FY 2024 rev $4.9M from 12 scanners; forecasts $18M for 2025; stock now on OTCQB after Nasdaq delisting

QT IMAGING HOLDINGS, INC.

2025-Q1 EPS reported -$0.40 revenue$2,798,415

FY 2024 commercial revenue $4.9M vs <$0.1M in 2023; 12 QT Breast Acoustic CT scanners shipped at 54% gross margin.
Insiders PIPE of $2.56M and $10.1M Lynrock Lake term loan closed; $5.4M for working capital; all short-term debt cleared.
Exclusive US distribution with NXC Imaging; manufacturing agreement with Canon Medical Systems Corporation.
Revenue forecast of $18M for 2025 and $27M for 2026.
Nasdaq initiated delisting proceedings; common stock now trades OTCQB under QTIH as of March 11, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.